Prevalence and spectrum of LRRC10 mutations associated with idiopathic dilated cardiomyopathy

  • Authors:
    • Xin-Kai Qu
    • Fang Yuan
    • Ruo-Gu Li
    • Lei Xu
    • Wei-Feng Jing
    • Hua Liu
    • Ying-Jia Xu
    • Min Zhang
    • Xu Liu
    • Wei-Yi Fang
    • Yi-Qing Yang
    • Xing-Biao Qiu
  • View Affiliations

  • Published online on: May 25, 2015     https://doi.org/10.3892/mmr.2015.3843
  • Pages: 3718-3724
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Dilated cardiomyopathy (DCM) is the most common form of primary myocardial disease. It is the most common cause of chronic congestive heart failure and the most frequent reason for heart transplantation in young adults. There is increasing evidence demonstrating that genetic defects are involved in the pathogenesis of idiopathic DCM. Recent studies have shown that genetically defective LRRC10 predisposes animals to DCM. However, the association of LRRC10 with DCM in humans has not been reported. In the current study, the whole coding region and flanking splice junction sites of the LRRC10 gene were sequenced in 220 unrelated patients with idiopathic DCM. The available relatives of the index patients harboring identified mutations and 200 unrelated ethnically matched healthy individuals used as controls were also genotyped for LRRC10. The functional effect of the LRRC10 mutations was analyzed in silico. As a result, two novel heterozygous LRRC10 mutations, p.L41V and p.L163I, were identified in two families with DCM, respectively, with a mutational prevalence of ~0.91%. Genetic analyses of the pedigrees showed that in each family, the mutation co-segregated with DCM was transmitted as an autosomal dominant trait with complete penetrance. The missense mutations were absent in 400 control chromosomes and the altered amino acids were completely conserved evolutionarily across various species. Functional analysis in silico indicated that the LRRC10 mutations were causative. This study firstly reports the association of LRRC10 mutations with enhanced susceptibility to DCM in humans, which provides novel insight into the molecular mechanism underpinning DCM, and contributes to the development of novel prophylactic and therapeutic strategies for DCM.

Introduction

Dilated cardiomyopathy (DCM) is characterized by ventricular chamber enlargement and contractile dysfunction with normal ventricular wall thickness in the absence of associated conditions, such as coronary heart disease, hypertension and cardiac valve disease. It is the most common form of primary myocardial disease, affecting ~1:2,500 (1). It is the most prevalent cause of chronic congestive heart failure and sudden cardiac death in individuals between the ages of 20 and 60 years-old, and is the most frequent reason for heart transplantation in humans (1,2). A previous study identified that mortality or cardiac transplantation occurred in 26% of patients with childhood DCM within 1 year of diagnosis and ~1% per year thereafter (3). Although certain acquired risk factors have been implicated in DCM, including viral myocarditis, myocardial infarction, arrhythmias and autoimmune disorders (4), in the majority of patients with DCM no secondary etiologies can be identified, this is defined as idiopathic DCM, among which 25–50% of DCM occur in at least two close relatives, hence termed familial DCM, and familial transmission of DCM has been observed to occur in an autosomal dominant, autosomal recessive or X-linked manner with variable expressivity and penetrance (1). Increasing evidence demonstrates that genetic defects are involved in the pathogenesis of idiopathic DCM, and mutations in >50 genes have been causally linked to idiopathic DCM (1,521). Nevertheless, these established DCM-associated genes are observed in less than a third of all cases and the genetic determinants underpinning DCM in an overwhelming majority of patients remain unclear (1,522).

Leucine rich repeat containing proteins (LRRCs), which contain multiple LRR motifs forming solenoid-shaped structures ideal for protein-protein interactions, have been involved in diverse cellular functions, including cell adhesion, signal transduction, ion channel expression, mechanical-stretch sensing, DNA repair and development (2325). As a family member of LRRCs, LRRC10 is a cardiac-specific factor exclusively expressed in embryonic cardiomyocytes and in the hearts of adult zebrafish, mice and humans, exhibiting pivotal roles in cardiac development and function (2628). In zebrafish, knockdown of LRRC10 using morpholinos resulted in severe cardiac morphogenic defects, including a cardiac looping failure accompanied by pericardial edema, and embryonic lethality between day 6 and 7 post fertilization. The LRRC10 morphants exhibited cardiac impairments, with decreased ejection fraction and cardiac output as well as reduced numbers of cardiomyocytes (29). In mice, targeted deletion of LRRC10 led to antenatal cardiac dysfunction and the development of DCM in early postnatal life (30). Furthermore, LRRC10 has been substantiated to interact physically with α-actin and α-actinin in the heart, forming a cytoskeletal complex, and mutations in α-actin and α-actinin have been causally linked to human DCM (3032). These previous studies warrant the screening of LRRC10 as a novel DCM candidate gene in humans.

Materials and methods

Study subjects

To evaluate the prevalence and spectrum of LRRC10 mutations in patients with idiopathic DCM, a cohort of 220 genetically unrelated patients with idiopathic DCM was enrolled from the Han Chinese population, who were referred to Shanghai Chest Hospital between January 1st 2011 and December 31st 2013. The available relatives of the index patients harboring the identified LRRC10 mutations were also included in this study. A total of 200 ethnically-matched unrelated healthy individuals were recruited as controls. All participants underwent a detailed medical history, physical examination, electrocardiogram, chest radiography, echocardiography and exercise tolerance test. Cardiac catheterization, coronary angiography and cardiac magnetic resonance imaging were applied only if there was a strong clinical indication. Medical records were also reviewed for deceased or unavailable relatives. Diagnosis of idiopathic DCM was made according to the criteria established by the World Health Organization/International Society and Federation of Cardiology Task Force on the Classification of Cardiomyopathy: A left ventricular end-diastolic diameter >27 mm/m2 and an ejection fraction <40% or fractional shortening <25% in the absence of abnormal loading conditions, coronary artery disease, congenital heart disease and other systemic diseases (11,16,18,33). Subjects were excluded if they had poor echocardiographic image quality, or coexistent entities that may lead to cardiac systolic dysfunction, such as essential hypertension, coronary artery disease, and valvular heart disease. Familial DCM was defined when DCM occurred in two or more first-degree relatives. Peripheral venous blood samples from all the participants were collected. The clinical investigations were conducted with researchers blinded to the genotyping data. The study was conducted in accordance with the principles outlined in the Declaration of Helsinki of 1975 as revised in 2008. The study protocol was reviewed and approved by the local institutional ethics committee of Shanghai Chest Hospital, Shanghai Jiao Tong University (Shanghai, China). Prior to commencement of the study, all participants provided written informed consent for the use of their blood specimens for genetic analysis.

Genetic analysis of LRRC10

Genomic DNA was isolated from blood lymphocytes of each participant with Wizard Genomic DNA Purification kit (Promega Corporation, Madison, WI, USA). According to the referential genomic DNA sequence of the LRRC10 gene (GenBank accession no. NC_000012), the primers to amplify the entire coding region and flanking splice junction sites of LRRC10 by polymerase chain reaction (PCR) were designed as shown in Table I. The coding exon and exon-intron boundaries of LRRC10 were PCR-sequenced in 220 unrelated patients with idiopathic DCM. When LRRC10 mutations were detected in index patients, the available relatives of the mutation carriers and 200 unrelated healthy controls were subsequently genotyped for LRRC10. PCR was performed using HotStar Taq DNA Polymerase (Qiagen, Hilden, Germany) on a Verti Thermal Cycler (Applied Biosystems, Foster, CA, USA) with standard conditions and concentrations of reagents. Both strands of each PCR product were sequenced with a BigDye® Terminator v3.1 Cycle Sequencing kit (Applied Biosystems) under an ABI PRISM 3130 XL DNA analyzer (Applied Biosystems).

Table I

Primers to amplify the whole coding region and splice junction sites of the LRRC10 gene.

Table I

Primers to amplify the whole coding region and splice junction sites of the LRRC10 gene.

ExonForward primer (5′ to 3′)Reverse primer (5′ to 3′)Amplicon (bp)
1-atag, gat, agg, ccc, cag, agc, aggga, gac, tca, gct, cac, aga, cc520
1-bgca, cct, tga, aac, agc, tct, gcaga, aca, tgc, tgc, agt, tgg, gt600

[i] bp, base pairs

DNA sequences were analyzed with the DNA Sequencing Analysis Software v5.1 (Applied Biosystems). A sequence variation was verified by re-sequencing of an independent PCR-generated amplicon from the same subject. Additionally, for an identified variation, the public databases for human sequence variations, including single nucleotide polymorphism (SNP; http://www.ncbi.nlm.nih.gov/SNP) and human gene mutation (HGM; http://www.hgmd.org) databases, were analyzed to confirm its novelty.

Multiple alignments of LRRC10 amino acid sequences among species

Using the online MUSCLE program (version3.6;http://www.ncbi.nlm.nih.gov/homologene?cmd=Retrieve&dopt=MultipleAlignment&list_uids=17154), the human LRRC10 amino acid sequence was aligned with those of chimpanzee, monkey, dog, cattle, mouse, rat, fowl, zebrafish and frog.

Functional analysis of the LRRC10 sequence variations in silico

The disease-causing potential of LRRC10 sequence variations were evaluated by MutationTaster (an online program at http://www.mutationtaster.org), which automatically gave a probability for the variation to be either a causative mutation or a benign polymorphism. Notably, the P-value used here is the probability of the correct prediction rather than the probability of error as used in t-test statistics (i.e., a value close to 1 indicates a high accuracy of the prediction).

Statistical analysis

Quantitative values are expressed as the mean ± standard deviation. Continuous data were tested for normality of distribution and Student's unpaired t-test was used for the comparison of numeric variables between two groups. Comparison of the categorical variables between two groups was made using Pearson's χ2 test or Fisher's exact test when appropriate. A 2-tailed P<0.05 was considered to indicate a statistically significant difference.

Results

Baseline clinical characteristics of the study participants

A detailed evaluation of clinical data from 220 unrelated patients with idiopathic DCM and 200 control individuals was made. None of them had acquired risk factors for DCM. All the patients manifested with a progressive DCM phenotype without congenital cardiovascular defects. The control individuals had no evidence of structural cardiac diseases, and their echocardiographic results were normal. The baseline clinical characteristics of the study participants are summarized in Table II.

Table II

Baseline clinical characteristics of the patients with DCM and control individuals.

Table II

Baseline clinical characteristics of the patients with DCM and control individuals.

VariableNo. of patients (n=220)No. of controls (n=200)P-value
Age (years)44.7±13.545.1±12.90.7569
Male (%)104 (47.3)95 (47.5)1.0000
Family history of DCM (%)62 (28.2)0 (0)<0.0001
SBP (mmHg)115.2±14.8125.4±10.6<0.0001
DBP (mmHg)77.0±8.584.9±6.2<0.0001
HR (beat per minute)86.7±10.075.1±9.4<0.0001
LVEDD (mm)69.3±7.546.8±6.3<0.0001
LVESD (mm)58.8±7.234.5±5.6<0.0001
LVEF (%)39.3±8.262.8±6.4<0.0001
NYHA function class (%)
 I35 (15.9)NANA
 II47 (21.4)NANA
 III92 (41.8)NANA
 IV46 (20.9)NANA

[i] DCM, dilated cardiomyopathy; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; LVEDD, left ventricular end-diastolic diameter; LVESD, left ventricular end-systolic diameter; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association; NA, not applicable or not available.

Identification of LRRC10 mutations

Using PCR-sequencing of the LRRC10 gene, two mutations were identified in 2 out of 220 unrelated patients with idiopathic DCM, respectively, with a mutational prevalence of ~0.91%. Specifically, a substitution of guanine for thymine in the first nucleotide of codon 41 (c.121T>G), predicting the transition of leucine (L) into valine (V) at amino acid position 41 (p.L41V), was identified in the index patient from family 1. A change of cytosine into adenine at nucleotide 487 (c.487C>A), equivalent to a displacement of leucine at amino acid 163 by isoleucine (p.L163I), was detected in the proband from family 2. The sequence chromatograms showing the identified heterozygous LRRC10 mutations compared with their control sequences are displayed in Fig. 1. The missense mutations were neither identified in the 400 control chromosomes nor reported in the SNP or HGM databases. Genetic screening of the families revealed that in each family the mutation was present in all affected living family members, but absent in unaffected family members examined. Analysis of the pedigrees demonstrated that in each family the mutation co-segregated with DCM was transmitted in an autosomal dominant manner with complete penetrance (Fig. 2). Notably, during the most recent follow up, atrial fibrillation was recorded by standard 12-lead electrocardiogram in 2 patients with DCM (I-1 and II-1 from family 2), implying that DCM may be a key cause of atrial fibrillation. The phenotypic characteristics and status of LRRC10 mutations of the affected living family members are listed in Table III.

Table III

Phenotypic characteristics and status of LRRC10 mutations of the affected living pedigree members.

Table III

Phenotypic characteristics and status of LRRC10 mutations of the affected living pedigree members.

SubjectGenderAge (years)Cardiac phenotypeLVEDD (mm)LVESD (mm)LVEF (%)LRRC10 mutation
Family 1
 II-2F57DCM786722L41V +/−
 III-1M32DCM645538L41V +/−
Family 2
 I-1M61DCM, AF725830L163I +/−
 II-1M36DCM, AF806925L163I +/−
 II-7F29DCM625036L163I +/−

[i] F, female; M, male; DCM, dilated cardiomyopathy; AF, atrial fibrillation; LVEDD, left ventricular end-diastolic diameter; LVESD, left ventricular end-systolic diameter; LVEF, left ventricular ejection fraction; +/−, heterozygous mutation.

Alignment of multiple LRRC10 protein sequences across various species

As shown in Fig. 3, a cross-species alignment of LRRC10 protein sequences exhibited that the altered amino acids of p.L41 and p.L163 were evolutionarily conserved, indicating that these amino acids are functionally important.

Causative potential of the LRRC10 variations

The LRRC10 sequence variations of c.121T>G and c.487C>A were predicted by MutationTaster to be disease-causing mutations with P-values of 0.982216 for c.121T>G and 0.999719 for c.487C>A. No SNPs in the altered regions were found in the MutationTaster database.

Discussion

In this study, two novel heterozygous LRRC10 mutations, p.L41V and p.L163I, were identified in two families with idiopathic DCM, respectively. In each family the missense mutation co-segregated with DCM was inherited as an autosomal dominant trait with complete penetrance. The two mutations, which were absent in the 400 reference chromosomes from an ethnically-matched control population, altered the amino acids that were evolutionarily conserved. Functional analysis in silico indicated that the mutations were pathogenic. Hence, it is likely that LRRC10 mutations predispose these mutation carriers to DCM.

In humans, LRRC10 maps to chromosome 12q15, coding for a protein of 227 amino acids. LRRC10 is exclusively expressed in the precardiac region in early embryos and in the adult heart, and exhibits dynamic intracellular expression patterns in cardiomyocytes (26). Cardiomyocytes from embryos and newborns show diffuse cytoplasmic and nuclear distribution of LRRC10. By contrast, a striated expression pattern of LRRC10 is observed in adult cardiomyocytes, which colocalizes with the markers for the Z-disc, sarcoplasmic reticulum and transverse tubule. A further study by electron micrograph demonstrate that LRRC10 localizes predominantly to the diad region where the sarcoplasmic reticulum interacts with the transverse tubule, adjacent to the Z-disc (26). The Z-disc appears as a fine dense line forming sarcomere boundaries in striated muscles, where actin myofilaments are crosslinked primarily by α-actinin (34). Therefore, the Z-disc is not only associated with lateral force transmission between sarcomeres, but also provides a mechanical link from the Z-disc myofilament to proteins in the peripheral subsarcolemmal costamere and eventually sarcolemma and extracellular matrix (35,36). Moreover, the Z-disc is crucial in sensing and transducing signals in response to biomechanical stress in the cardiomyocyte (35,37). Genetic deletion of several Z-disc and costameric proteins has been reported to cause DCM in mice, including Cypher (38), muscle LIM protein (39), enigma homologue protein (40), integrin-linked kinase (41) and vinculin (42). Furthermore, mutations in Cypher (43), muscle LIM protein (44), nexilin (45), myopalladin (46), integrin-linked kinase (47) and desmin (48) have been implicated in DCM in humans, indicating a key role for the dysfunction of Z-disc and costamere proteins in the pathogenesis of DCM. Given the fact that LRRC10 physically interacts with α-actin and α-actinin in the heart and directly interacts with all actin isoforms in vitro (30), mutant LRRC10 may confer increased vulnerability to DCM by disturbing the mechanical link between the Z-disc and the sarcolemma or cytoskeletal proteins.

The finding that genetically defective LRRC10 contributes to DCM may be partially ascribed to the abnormal development of the heart. As a cardiac-specific protein, LRRC10 is exclusively expressed in embryonic cardiomyocytes and the adult heart, exhibiting an essential role in cardiac development and function, possibly by interacting with other factors that are required for cardiac development and function (2628). In zebra fish, the LRRC10-knockdown morphants manifested with a reduced ejection fraction and cardiac output, as well as a decreased quantity of cardiomyocytes. There was also deregulation of two cardiac genes, including an increase in atrial natriuretic factor, a hallmark for heart failure, and a decrease in cardiac myosin light chain 2, an essential protein for cardiac contractility (29). In LRRC10-null mice, diminished cardiac systolic performance occurred in utero, prior to ventricular dilation observed in young adults. Gene expression profiling of the LRRC10-deletious embryonic hearts revealed dysregulation of the actin cytoskeleton as an early defective molecular signal in the absence of LRRC10 (30). By contrast, microarray analyses of adult LRRC10-knockout hearts identified upregulation of oxidative phosphorylation and cardiac muscle contraction pathways during the progression of DCM (30). These experimental data demonstrate that LRRC10 is necessary for proper cardiac development and cardiac function. However, the exact mechanism by which the identified LRRC10 mutations result in or confer susceptibility to DCM remains to be elucidated by experiments in vivo and in vitro.

Notably, atrial fibrillation was documented in two DCM patients harboring an LRRC10 mutation. Furthermore, LRRC10 has been recognized as a transcriptional target of Nkx2.5 and GATA4 (49), and Nkx2.5 and GATA4 have been causally linked to DCM and atrial fibrillation (11,16,18,5059). These observational results imply that atrial fibrillation and DCM may share a common genetic origin.

In conclusion, the current study firstly provides genetic evidence supporting that functionally compromised LRRC10 contributes to the pathogenesis of DCM, and suggests potential implications of prenatal prophylaxis and gene-specific treatment of DCM.

Acknowledgments

The authors are thankful to the participants for their dedication to the study. This study was supported in part by grants from the National Natural Science Fund of China (grant no. 81270161), the Natural Science Fund of Shanghai, China (grant nos. 13ZR1438400 and 14ZR1438000) and the Key Program for Basic Research of Shanghai, China (grant no. 14JC1405500).

References

1 

McNally EM, Golbus JR and Puckelwartz MJ: Genetic mutations and mechanisms in dilated cardiomyopathy. J Clin Invest. 123:19–26. 2013. View Article : Google Scholar : PubMed/NCBI

2 

Koutalas E, Kanoupakis E and Vardas P: Sudden cardiac death in non-ischemic dilated cardiomyopathy: a critical appraisal of existing and potential risk stratification tools. Int J Cardiol. 167:335–341. 2013. View Article : Google Scholar

3 

Alexander PM, Daubeney PE, Nugent AW, Lee KJ, Turner C, Colan SD, Robertson T, Davis AM, Ramsay J, Justo R, Sholler GF, et al: National Australian childhood cardiomy-opathy study: Long-term outcomes of dilated cardiomyopathy diagnosed during childhood: results from a national population-based study of childhood cardiomyopathy. Circulation. 128:2039–2046. 2013. View Article : Google Scholar : PubMed/NCBI

4 

Yoshikawa T: Contribution of acquired factors to the pathogenesis of dilated cardiomyopathy: The cause of dilated cardiomyopathy: Genetic or acquired? (Acquired-Side). Circ J. 75:1766–1773. 2011. View Article : Google Scholar

5 

Wahbi K, Béhin A, Bécane HM, Leturcq F, Cossée M, Laforêt P, Stojkovic T, Carlier P, Toussaint M, Gaxotte V, Cluzel P, et al: Dilated cardiomyopathy in patients with mutations in anoctamin 5. Int J Cardiol. 168:76–79. 2013. View Article : Google Scholar

6 

Ruppert V, Meyer T, Richter A, Maisch B and Pankuweit S: German competence network of heart failure: Identification of a missense mutation in the melusin-encoding ITGB1BP2 gene in a patient with dilated cardiomyopathy. Gene. 512:206–210. 2013. View Article : Google Scholar

7 

Luo R, Li X, Fan X, Yuan W and Wu X: Association of tumor necrosis factor-α gene G-308A polymorphism with dilated cardiomyopathy: a meta-analysis. DNA Cell Biol. 32:130–137. 2013. View Article : Google Scholar : PubMed/NCBI

8 

Meyer T, Ruppert V, Ackermann S, Richter A, Perrot A, Sperling SR, Posch MG, Maisch B and Pankuweit S: German competence network heart failure: Novel mutations in the sarcomeric protein myopalladin in patients with dilated cardio-myopathy. Eur J Hum Genet. 21:294–300. 2013. View Article : Google Scholar :

9 

Xi HL, Liu JF, Li L and Wan J: Relationship between dilated cardiomyopathy and the E23K and I337V polymorphisms in the Kir6.2 subunit of the KATP channel. Genet Mol Res. 12:4383–4392. 2013. View Article : Google Scholar : PubMed/NCBI

10 

Pankuweit S, Ruppert V, Jónsdóttir T, Müller HH and Meyer T: German competence network of heart failure: The HLA class II allele DQB1 0309 is associated with dilated cardiomyopathy. Gene. 531:180–183. 2013. View Article : Google Scholar : PubMed/NCBI

11 

Li RG, Li L, Qiu XB, Yuan F, Xu L, Li X, Xu YJ, Jiang WF, Jiang JQ, Liu X, Fang WY, et al: GATA4 loss-of-function mutation underlies familial dilated cardiomyopathy. Biochem Biophys Res Commun. 439:591–596. 2013. View Article : Google Scholar : PubMed/NCBI

12 

Paavola J, Schliffke S, Rossetti S, Kuo IY, Yuan S, Sun Z, Harris PC, Torres VE and Ehrlich BE: Polycystin-2 mutations lead to impaired calcium cycling in the heart and predispose to dilated cardiomyopathy. J Mol Cell Cardiol. 58:199–208. 2013. View Article : Google Scholar : PubMed/NCBI

13 

Wells QS, Becker JR, Su YR, Mosley JD, Weeke P, D'Aoust L, Ausborn NL, Ramirez AH, Pfotenhauer JP, Naftilan AJ, Markham L, et al: Whole exome sequencing identifies a causal RBM20 mutation in a large pedigree with familial dilated cardiomyopathy. Circ Cardiovasc Genet. 6:317–326. 2013. View Article : Google Scholar : PubMed/NCBI

14 

Dhandapany PS, Razzaque MA, Muthusami U, Kunnoth S, Edwards JJ, Mulero-Navarro S, Riess I, Pardo S, Sheng J, Rani DS, Rani B, et al: RAF1 mutations in childhood-onset dilated cardiomyopathy. Nat Genet. 46:635–639. 2014. View Article : Google Scholar : PubMed/NCBI

15 

Amin AS: SCN5A-related dilated cardiomyopathy: What do we know? Heart Rhythm. 11:1454–1455. 2014. View Article : Google Scholar : PubMed/NCBI

16 

Li J, Liu WD, Yang ZL, Yuan F, Xu L, Li RG and Yang YQ: Prevalence and spectrum of GATA4 mutations associated with sporadic dilated cardiomyopathy. Gene. 548:174–181. 2014. View Article : Google Scholar : PubMed/NCBI

17 

Petchey LK, Risebro CA, Vieira JM, Roberts T, Bryson JB, Greensmith L, Lythgoe MF and Riley PR: Loss of Prox1 in striated muscle causes slow to fast skeletal muscle fiber conversion and dilated cardiomyopathy. Proc Natl Acad Sci USA. 111:9515–9520. 2014. View Article : Google Scholar : PubMed/NCBI

18 

Zhao L, Xu JH, Xu WJ, Yu H, Wang Q, Zheng HZ, Jiang WF, Jiang JF and Yang YQ: A novel GATA4 loss-of-function mutation responsible for familial dilated cardiomyopathy. Int J Mol Med. 33:654–660. 2014.

19 

Zhang M, Chen J, Si D, Zheng Y, Jiao H, Feng Z, Hu Z and Duan R: Whole exome sequencing identifies a novel EMD mutation in a Chinese family with dilated cardiomyopathy. BMC Med Genet. 15:772014. View Article : Google Scholar : PubMed/NCBI

20 

Matsa LS, Sagurthi SR, Ananthapur V, Nalla S and Nallari P: Endothelin 1 gene as a modifier in dilated cardiomyopathy. Gene. 548:256–262. 2014. View Article : Google Scholar : PubMed/NCBI

21 

Franaszczyk M, Bilinska ZT, Sobieszczańska-Małek M, Michalak E, Sleszycka J, Sioma A, Małek ŁA, Kaczmarska D, Walczak E, Włodarski P, Hutnik Ł, et al: The BAG3 gene variants in Polish patients with dilated cardiomyopathy: four novel mutations and a genotype-phenotype correlation. J Transl Med. 12:1922014. View Article : Google Scholar : PubMed/NCBI

22 

Flack E and Kannankeril PJ: The genetics of dilated cardiomyopathy. Heart Rhythm. 9:397–398. 2012. View Article : Google Scholar

23 

Kobe B and Deisenhofer J: Proteins with leucine-rich repeats. Curr Opin Struct Biol. 5:409–416. 1995. View Article : Google Scholar : PubMed/NCBI

24 

Yan J and Aldrich RW: LRRC26 auxiliary protein allows BK channel activation at resting voltage without calcium. Nature. 466:513–516. 2010. View Article : Google Scholar : PubMed/NCBI

25 

Will RD, Eden M, Just S, Hansen A, Eder A, Frank D, Kuhn C, Seeger TS, Oehl U, Wiemann S, Korn B, et al: Myomasp/LRRC39, a heart- and muscle-specific protein, is a novel component of the sarcomeric M-band and is involved in stretch sensing. Circ Res. 107:1253–1264. 2010. View Article : Google Scholar : PubMed/NCBI

26 

Kim KH, Kim TG, Micales BK, Lyons GE and Lee Y: Dynamic expression patterns of leucine-rich repeat containing protein 10 in the heart. Dev Dyn. 236:2225–2234. 2007. View Article : Google Scholar : PubMed/NCBI

27 

Nakane T, Satoh T, Inada Y, Nakayama J, Itoh F and Chiba S: Molecular cloning and expression of HRLRRP, a novel heart-restricted leucine-rich repeat protein. Biochem Biophys Res Commun. 314:1086–1092. 2004. View Article : Google Scholar : PubMed/NCBI

28 

Adameyko II, Mudry RE, Houston-Cummings NR, Veselov AP, Gregorio CC and Tevosian SG: Expression and regulation of mouse SERDIN1, a highly conserved cardiac-specific leucine-rich repeat protein. Dev Dyn. 233:540–552. 2005. View Article : Google Scholar : PubMed/NCBI

29 

Kim KH, Antkiewicz DS, Yan L, Eliceiri KW, Heideman W, Peterson RE and Lee Y: Lrrc10 is required for early heart development and function in zebrafish. Dev Biol. 308:494–506. 2007. View Article : Google Scholar : PubMed/NCBI

30 

Brody MJ, Hacker TA, Patel JR, Feng L, Sadoshima J, Tevosian SG, Balijepalli RC, Moss RL and Lee Y: Ablation of the cardiac-specific gene leucine-rich repeat containing 10 (Lrrc10) results in dilated cardiomyopathy. PLoS One. 7:e516212012. View Article : Google Scholar : PubMed/NCBI

31 

Olson TM, Michels VV, Thibodeau SN, Tai YS and Keating MT: Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science. 280:750–752. 1998. View Article : Google Scholar : PubMed/NCBI

32 

Mohapatra B, Jimenez S, Lin JH, Bowles KR, Coveler KJ, Marx JG, Chrisco MA, Murphy RT, Lurie PR, Schwartz RJ, Elliott PM, et al: Mutations in the muscle LIM protein and alpha-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis. Mol Genet Metab. 80:207–215. 2003. View Article : Google Scholar : PubMed/NCBI

33 

Elliott P, O'Mahony C, Syrris P, Evans A, Rivera Sorensen C, Sheppard MN, Carr-White G, Pantazis A and McKenna WJ: Prevalence of desmosomal protein gene mutations in patients with dilated cardiomyopathy. Circ Cardiovasc Genet. 3:314–322. 2010. View Article : Google Scholar : PubMed/NCBI

34 

Luther PK: The vertebrate muscle Z-disc: sarcomere anchor for structure and signalling. J Muscle Res Cell Motil. 30:171–185. 2009. View Article : Google Scholar : PubMed/NCBI

35 

Frank D and Frey N: Cardiac Z-disc signaling network. J Biol Chem. 286:9897–9904. 2011. View Article : Google Scholar : PubMed/NCBI

36 

Ervasti JM: Costameres: the Achilles' heel of Herculean muscle. J Biol Chem. 278:13591–13594. 2003. View Article : Google Scholar : PubMed/NCBI

37 

Hoshijima M: Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk, titin and associated structures. Am J Physiol Heart Circ Physiol. 290:H1313–H1325. 2006. View Article : Google Scholar : PubMed/NCBI

38 

Zheng M, Cheng H, Li X, Zhang J, Cui L, Ouyang K, Han L, Zhao T, Gu Y, Dalton ND, Bang ML, et al: Cardiac-specific ablation of Cypher leads to a severe form of dilated cardiomyopathy with premature death. Hum Mol Genet. 18:701–713. 2009. View Article : Google Scholar :

39 

Arber S, Hunter JJ, Ross J Jr, Hongo M, Sansig G, Borg J, Perriard JC, Chien KR and Caroni P: MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy and heart failure. Cell. 88:393–403. 1997. View Article : Google Scholar : PubMed/NCBI

40 

Cheng H, Kimura K, Peter AK, Cui L, Ouyang K, Shen T, Liu Y, Gu Y, Dalton ND, Evans SM, Knowlton KU, et al: Loss of enigma homolog protein results in dilated cardiomyopathy. Circ Res. 107:348–356. 2010. View Article : Google Scholar : PubMed/NCBI

41 

White DE, Coutu P, Shi YF, Tardif JC, Nattel S, St Arnaud R, Dedhar S and Muller WJ: Targeted ablation of ILK from the murine heart results in dilated cardiomyopathy and spontaneous heart failure. Genes Dev. 20:2355–2360. 2006. View Article : Google Scholar : PubMed/NCBI

42 

Zemljic-Harpf AE, Miller JC, Henderson SA, Wright AT, Manso AM, Elsherif L, Dalton ND, Thor AK, Perkins GA, McCulloch AD and Ross RS: Cardiac-myocyte-specific excision of the vinculin gene disrupts cellular junctions, causing sudden death or dilated cardiomyopathy. Mol Cell Biol. 27:7522–7537. 2007. View Article : Google Scholar : PubMed/NCBI

43 

Vatta M, Mohapatra B, Jimenez S, Sanchez X, Faulkner G, Perles Z, Sinagra G, Lin JH, Vu TM, Zhou Q, Bowles KR, et al: Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. J Am Coll Cardiol. 42:2014–2027. 2003. View Article : Google Scholar : PubMed/NCBI

44 

Knöll R, Hoshijima M, Hoffman HM, Person V, Lorenzen-Schmidt I, Bang ML, Hayashi T, Shiga N, Yasukawa H, Schaper W, McKenna W, et al: The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell. 111:943–955. 2002. View Article : Google Scholar

45 

Hassel D, Dahme T, Erdmann J, Meder B, Huge A, Stoll M, Just S, Hess A, Ehlermann P, Weichenhan D, Grimmler M, et al: Nexilin mutations destabilize cardiac Z-disks and lead to dilated cardiomyopathy. Nat Med. 15:1281–1288. 2009. View Article : Google Scholar : PubMed/NCBI

46 

Duboscq-Bidot L, Xu P, Charron P, Neyroud N, Dilanian G, Millaire A, Bors V, Komajda M and Villard E: Mutations in the Z-band protein myopalladin gene and idiopathic dilated cardio-myopathy. Cardiovasc Res. 77:118–125. 2008. View Article : Google Scholar

47 

Knöll R, Postel R, Wang J, Krätzner R, Hennecke G, Vacaru AM, Vakeel P, Schubert C, Murthy K, Rana BK, Kube D, et al: Lamininalpha4 and integrin-linked kinase mutations cause human cardiomyopathy via simultaneous defects in cardiomyocytes and endothelial cells. Circulation. 116:515–525. 2007. View Article : Google Scholar

48 

Li D, Tapscoft T, Gonzalez O, Burch PE, Quiñones MA, Zoghbi WA, Hill R, Bachinski LL, Mann DL and Roberts R: Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation. 100:461–464. 1999. View Article : Google Scholar : PubMed/NCBI

49 

Brody MJ, Cho E, Mysliwiec MR, Kim TG, Carlson CD, Lee KH and Lee Y: Lrrc10 is a novel cardiac-specific target gene of Nkx2-5 and GATA4. J Mol Cell Cardiol. 62:237–246. 2013. View Article : Google Scholar : PubMed/NCBI

50 

Pashmforoush M, Lu JT, Chen H, Amand TS, Kondo R, Pradervand S, Evans SM, Clark B, Feramisco JR, Giles W, Ho SY, et al: Nkx2-5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block. Cell. 117:373–386. 2004. View Article : Google Scholar : PubMed/NCBI

51 

Costa MW, Guo G, Wolstein O, Vale M, Castro ML, Wang L, Otway R, Riek P, Cochrane N, Furtado M, Semsarian C, et al: Functional characterization of a novel mutation in NKX2-5 associated with congenital heart disease and adult-onset cardiomyopathy. Circ Cardiovasc Genet. 6:238–247. 2013. View Article : Google Scholar : PubMed/NCBI

52 

Gutierrez-Roelens I, De Roy L, Ovaert C, Sluysmans T, Devriendt K, Brunner HG and Vikkula M: A novel CSX/NKX2-5 mutation causes autosomal-dominant AV block: are atrial fibrillation and syncopes part of the phenotype? Eur J Hum Genet. 14:1313–1316. 2006. View Article : Google Scholar : PubMed/NCBI

53 

Huang RT, Xue S, Xu YJ, Zhou M and Yang YQ: A novel NKX2.5 loss-of-function mutation responsible for familial atrial fibrillation. Int J Mol Med. 31:1119–1126. 2013.PubMed/NCBI

54 

Xie WH, Chang C, Xu YJ, Li RG, Qu XK, Fang WY, Liu X and Yang YQ: Prevalence and spectrum of Nkx2.5 mutations associated with idiopathic atrial fibrillation. Clinics (Sao Paulo). 68:777–784. 2013. View Article : Google Scholar

55 

Yu H, Xu JH, Song HM, Zhao L, Xu WJ, Wang J, Li RG, Xu L, Jiang WF, Qiu XB, Jiang JQ, et al: Mutational spectrum of the NKX2-5 gene in patients with lone atrial fibrillation. Int J Med Sci. 11:554–563. 2014. View Article : Google Scholar : PubMed/NCBI

56 

Posch MG, Boldt LH, Polotzki M, Richter S, Rolf S, Perrot A, Dietz R, Ozcelik C and Haverkamp W: Mutations in the cardiac transcription factor GATA4 in patients with lone atrial fibrillation. Eur J Med Genet. 53:201–203. 2010. View Article : Google Scholar : PubMed/NCBI

57 

Yang YQ, Wang MY, Zhang XL, Tan HW, Shi HF, Jiang WF, Wang XH, Fang WY and Liu X: GATA4 loss-of-function mutations in familial atrial fibrillation. Clin Chim Acta. 412:1825–1830. 2011. View Article : Google Scholar : PubMed/NCBI

58 

Jiang JQ, Shen FF, Fang WY, Liu X and Yang YQ: Novel GATA4 mutations in lone atrial fibrillation. Int J Mol Med. 28:1025–1032. 2011.PubMed/NCBI

59 

Wang J, Sun YM and Yang YQ: Mutation spectrum of the GATA4 gene in patients with idiopathic atrial fibrillation. Mol Biol Rep. 39:8127–8135. 2012. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

September-2015
Volume 12 Issue 3

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Qu X, Yuan F, Li R, Xu L, Jing W, Liu H, Xu Y, Zhang M, Liu X, Fang W, Fang W, et al: Prevalence and spectrum of LRRC10 mutations associated with idiopathic dilated cardiomyopathy. Mol Med Rep 12: 3718-3724, 2015
APA
Qu, X., Yuan, F., Li, R., Xu, L., Jing, W., Liu, H. ... Qiu, X. (2015). Prevalence and spectrum of LRRC10 mutations associated with idiopathic dilated cardiomyopathy. Molecular Medicine Reports, 12, 3718-3724. https://doi.org/10.3892/mmr.2015.3843
MLA
Qu, X., Yuan, F., Li, R., Xu, L., Jing, W., Liu, H., Xu, Y., Zhang, M., Liu, X., Fang, W., Yang, Y., Qiu, X."Prevalence and spectrum of LRRC10 mutations associated with idiopathic dilated cardiomyopathy". Molecular Medicine Reports 12.3 (2015): 3718-3724.
Chicago
Qu, X., Yuan, F., Li, R., Xu, L., Jing, W., Liu, H., Xu, Y., Zhang, M., Liu, X., Fang, W., Yang, Y., Qiu, X."Prevalence and spectrum of LRRC10 mutations associated with idiopathic dilated cardiomyopathy". Molecular Medicine Reports 12, no. 3 (2015): 3718-3724. https://doi.org/10.3892/mmr.2015.3843